IL7 and idiopathic pulmonary fibrosis: After a series of sensitivity analyzes and further analyses, including Cochrane’s Q test, MR-Egger regression, colocalization analysis, pQTL analysis, we have discovered that IL-7 holds the most promising potential as a therapeutic target for IPF susceptibility.